Login / Signup

Patients with polyethylene glycol allergy can experience immediate-type hypersensitivity reactions after exposure to analog substances.

Yosuke YoshimotoJunichiro Tezuka
Published in: BMJ case reports (2023)
Polyethylene glycol (PEG) allergy has been recently observed after COVID-19 mRNA vaccination. We present a case of a patient with a history of two hospitalisations for unexplained recurrence of immediate-type hypersensitivity reactions and anaphylaxis who was diagnosed with PEG allergy in early childhood. Subsequently, he was instructed to avoid using PEG-containing daily necessities and drugs. However, in middle childhood, he presented with immediate-type hypersensitivity reactions after taking PEG-free antibiotics. The prick test was positive for the whole drug but negative for its active ingredient. PEG can cross-react with compounds with a C-C-O skeleton as analogue substances; accordingly, the presence of a substance with a similar skeleton in the additive may have been the causative factor. Our findings indicate that patients with PEG allergy may experience immediate-type hypersensitivity reactions to analogue substances.
Keyphrases
  • drug delivery
  • drug induced
  • atopic dermatitis
  • drinking water
  • sars cov
  • coronavirus disease
  • physical activity
  • case report
  • binding protein
  • free survival
  • childhood cancer